Australian Metals and Mining Stock News

Australian shares are entering the weekend on a steady note, with investors showing patience amid ongoing geopolitical discussions and national energy security measures. In this context, penny stocks—though often considered a term from past trading days—still represent viable opportunities for growth. These smaller or newer companies can offer significant potential when backed by strong financials, and this article explores three such promising stocks on the ASX that may present hidden value...

MAAS Group Holdings (ASX:MGH) has been actively running its on market share buy back, regularly repurchasing ordinary shares. For you as an investor, that kind of capital management puts the spotlight on per share outcomes. See our latest analysis for MAAS Group Holdings. MGH’s recent buy back activity comes as the share price trades at A$4.30, with a 1 day share price return of 2.38% and a 7 day share price return of 6.97%. This is set against a 30 day share price return of a 14.85% decline...

Why Megaport Shares Are Back at Early 2025 Levels Megaport (ASX:MP1) is back in focus after its share price slid to a new 52 week low, despite the company reporting strong double digit revenue growth and improving EBITDA margins. This pullback, which has taken the stock to levels last seen in January 2025, reflects investor attention on valuation and the durability of current earnings momentum rather than on headline revenue figures. See our latest analysis for Megaport. Over the past year,...

Recent funding support and prototype orders are putting IperionX (ASX:IPX) back in focus, as investors consider whether advancing commercialization efforts can translate into repeat output and more durable demand across its target end markets. See our latest analysis for IperionX. The latest moves in IperionX’s share price, including a 17.94% 7 day share price return after a weaker 90 day share price return of 31.44% and a very large 3 year total shareholder return, suggest momentum has...

In early April 2026, Orora announced a meaningful earnings reset for its Saverglass division after halting bottle production at its Ras Al Khaimah facility in the UAE due to Middle East conflict–related disruption and supply chain challenges. The decision to keep the UAE furnace in closed-loop “hot” mode while shifting production to Mexico underscores how geopolitical risk can quickly reshape Orora’s operational footprint and near-term earnings visibility. Next, we’ll examine how...

Washington H. Soul Pattinson and related entities recently sold 61.5 million TPG Telecom shares for about A$245 million and ceased to be substantial shareholders, while long-time representative Robert Millner retired from the TPG board following the May 2026 AGM. This combination of ownership exit and board change reshapes TPG Telecom’s long-term shareholder mix and governance links to a formerly influential investor. Next, we’ll examine how Soul Patts’ exit from the register may influence...

Event context and recent share performance National Storage REIT (ASX:NSR) has drawn fresh attention after a period of steady trading, with the units last closing at A$2.79 and delivering a 0.7% return over the past week. Over the past month and past 3 months, returns of 1.1% and 1.5% sit alongside a 1 year total return of 35.8%. This puts recent price moves in the context of a longer multi year track record. See our latest analysis for National Storage REIT. Taken together, the modest recent...

GQG Partners (ASX:GQG) has drawn attention after its Emerging Markets Equity Fund sold nearly 1.29 crore shares of ITC Hotels, trimming its stake from 1.97% to 1.35% through an open market transaction. See our latest analysis for GQG Partners. At a latest share price of A$1.78, GQG Partners has delivered a 3 year total shareholder return of 65.61%, even as its year to date share price return of 1.14% suggests momentum has cooled in the short term. If GQG’s portfolio moves have you thinking...

Sonic Healthcare recently came under pressure as sector-wide headwinds, including currency shifts, US tariffs, and rising labour costs, weighed on sentiment toward ASX-listed healthcare providers. This sector-driven weakness has put a spotlight on how Sonic’s globally diversified diagnostics operations and existing cost-efficiency efforts might respond to a tougher operating backdrop. We’ll now examine how these sector-wide cost and currency pressures could reshape Sonic Healthcare’s...

March activity surprise puts ASX:ASX in focus ASX (ASX:ASX) is back on investor watch after its March 2026 activity update showed a turnaround in capital flows and heavier trading across cash equities, futures, and options on the exchange. See our latest analysis for ASX. The March activity surprise has arrived alongside strong near term momentum, with a 2.19% 1 day and 19.21% 30 day share price return. However, the 1 year total shareholder return of 11.13% and 5 year total shareholder return...

Strickland Metals has advanced its 8.6Moz AuEq Rogozna Project in Serbia, confirming carbonate replacement lead-zinc-silver mineralisation at Obradov Potok and funding an extensive 2026 drilling programme with a recent A$55,000,000 placement. This combination of a large-scale gold resource, validation of a copper-gold skarn exploration model, and backing from major shareholder Zijin Mining reframes Rogozna as a potential cornerstone European gold development. We’ll now examine how the...

Markets are being pulled around by energy shocks, inflation worries, and changing interest rate expectations, and many investors are looking for cash flow that feels more reliable than day to day price moves. That is where the Dividend Fortresses screener comes in. It focuses on stocks with 5%+ dividend yields that aim to keep paying investors even when headlines turn rough. In this article, you will see 3 of the strongest candidates from that screener, why they stand out in the current macro...

If you are wondering whether Alkane Resources is still attractively priced after a strong run, the next sections will walk through what the current share price might be implying. Over the last year, the stock has returned 157.1%, with moves of 20.8% over 7 days, 12.9% over 30 days, and 30.4% year to date, which may signal that expectations and perceived risks have shifted recently. Recent news coverage has focused on Alkane Resources as part of ongoing interest in the Australian materials...

Qantas Airways (ASX:QAN) is drawing fresh attention as recovering domestic and international travel demand supports rising passenger volumes and revenue, with its frequent flyer program and strong home-market businesses helping offset fuel and economic risks. See our latest analysis for Qantas Airways. The recent recovery story is increasingly reflected in the share price, with a 7 day share price return of 7.49% and a 30 day gain of 6.00%, contrasting with a 90 day share price return showing...

We'd be surprised if Titomic Limited ( ASX:TTT ) shareholders haven't noticed that the Independent Non-Executive...

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Litchfield...

Even if it's not a huge purchase, we think it was good to see that Samir Hallab, the Independent Non-Executive Director...

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Many Peaks...

Whilst it may not be a huge deal, we thought it was good to see that the Cannindah Resources Limited ( ASX:CAE...

Xero’s 35% 2026 share price slide puts business fundamentals in focus Xero (ASX:XRO) has drawn extra attention after a 35% share price fall in 2026, as investors weigh concerns about artificial intelligence disruptions and higher interest rates against the company’s subscription model and global small business footprint. See our latest analysis for Xero. The recent 35% 2026 share price decline, including a 33.5% 90 day share price return and 53.9% 1 year total shareholder return, points to...

Earlier this week, Mesoblast Limited announced that the FDA granted Investigational New Drug clearance to proceed directly to a registrational trial of Ryoncil (remestemcel-L-rknd) in 76 children with Duchenne muscular dystrophy, using time-to-stand at nine months as the primary approval endpoint. This move extends the use of the first FDA-approved mesenchymal stromal cell therapy beyond steroid‑refractory pediatric graft-versus-host disease and leverages a partnership with Parent Project...

Charter Hall Group recently secured a A$1.20 billion diversified direct property mandate from an existing institutional client, expanding its cross-sector funds under management across Australian office, industrial and logistics, retail, and social infrastructure assets. This repeat mandate highlights the depth of institutional confidence in Charter Hall’s multi-sector property platform and its ability to attract sizeable, income-focused capital commitments. We’ll now explore how this new...

4DMedical (ASX:4DX) has attracted investor attention after its CT:VQ imaging technology secured CE Mark certification for commercial use in the European Union, with a rapid regional rollout now planned. See our latest analysis for 4DMedical. Investors have reacted strongly to the CE Mark news, with the A$6.80 share price reflecting a 55.25% 1 month share price return and a very large 1 year total shareholder return. This suggests momentum has been building rather than fading. If CT based lung...

Guzman y Gomez recently reported past third-quarter FY26 network sales growth of 19.5%, opened five new Australian restaurants, and expanded its global footprint to 278 locations, alongside launching a partnership with Uber Eats that lifted delivery performance and guest frequency. By combining rapid store openings with an intensified delivery push through Uber Eats, the company is increasingly leveraging both physical and digital channels to deepen customer engagement across its...